logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Nasdaq Biotechnology Index closes up nearly 1.5%

date
27/09/2025
Stock components Applied Therapeutics rose by 119.56%, Crinetics Pharma rose by 27.92%, and Annexon rose by 20.79%, ranking third in performance. Kyverna Therapeutics fell by 3.94%, Ardelyx fell by 6.88%, and PepGen fell by 13.94%, ranking last.
Latest
2 m ago
U.S. Department of Justice: Firing Federal Reserve Governor Cook will not lead to "financial market disaster"
4 m ago
Downgraded three times within two weeks! Political deadlock in France intensifies debt crisis
5 m ago
Trump's new drug tariff policy details released, EU and Japan exempted, British drugs may face 100% tariff.
6 m ago
Apple (AAPL.US) secretly developing internal AI chat application in preparation for big upgrade to Siri.
11 m ago
The French Prime Minister said that efforts will be made to reduce the budget deficit rate in 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.